東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back to Search results for [ null ]

Switch To: Labeled | MARC Mode | ISBD

Utilizing the WTO-TRIPS flexibilitie...

Wabwire, Joshua.

Linked to FindBook

Google Book

Amazon

博客來

Utilizing the WTO-TRIPS flexibilities on public health at a regional level: A critical review of the east African community framework.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Utilizing the WTO-TRIPS flexibilities on public health at a regional level: A critical review of the east African community framework./
Author:	Wabwire, Joshua.
Description:	86 p.
Notes:	Source: Masters Abstracts International, Volume: 54-06.
Contained By:	Masters Abstracts International54-06(E).
Subject:	Intellectual property. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1594680
ISBN:	9781321920383

Utilizing the WTO-TRIPS flexibilities on public health at a regional level: A critical review of the east African community framework.
Wabwire, Joshua.

Utilizing the WTO-TRIPS flexibilities on public health at a regional level: A critical review of the east African community framework. - 86 p.

Source: Masters Abstracts International, Volume: 54-06.

Thesis (LLM)--University of Pretoria (South Africa), 2014.

The East African Community (EAC) states recently adopted a policy on utilising the WTOTRIPS flexibilities on public health. The policy spells out a number of flexibilities and the minimum standards thereof to be enacted in domestic legislation. This study critically reviews this policy. In doing this, the study notes that the EAC member states, like most developing states, have very low per capita income levels. The people are too poor to afford expensive medicines. At the same time, these countries are faced with peculiar, region-specific diseases, the so-called 'African diseases.' Already, these diseases have been neglected by foreign pharmaceuticals reluctant to invest in developing medicines for poor markets. There are no established pharmaceuticals in the EAC states.

ISBN: 9781321920383Subjects--Topical Terms:

572975
Intellectual property.

Utilizing the WTO-TRIPS flexibilities on public health at a regional level: A critical review of the east African community framework.
LDR:02477nmm a2200289 4500 001 2073653
005 20160926135132.5
008 170521s2014 ||||||||||||||||| ||eng d
020 $a 9781321920383
035 $a (MiAaPQ)AAI1594680
035 $a AAI1594680
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wabwire, Joshua. $3 3188929
245 1 0 $a Utilizing the WTO-TRIPS flexibilities on public health at a regional level: A critical review of the east African community framework.
300 $a 86 p.
500 $a Source: Masters Abstracts International, Volume: 54-06.
500 $a Adviser: Femi Soyeju.
502 $a Thesis (LLM)--University of Pretoria (South Africa), 2014.
520 $a The East African Community (EAC) states recently adopted a policy on utilising the WTOTRIPS flexibilities on public health. The policy spells out a number of flexibilities and the minimum standards thereof to be enacted in domestic legislation. This study critically reviews this policy. In doing this, the study notes that the EAC member states, like most developing states, have very low per capita income levels. The people are too poor to afford expensive medicines. At the same time, these countries are faced with peculiar, region-specific diseases, the so-called 'African diseases.' Already, these diseases have been neglected by foreign pharmaceuticals reluctant to invest in developing medicines for poor markets. There are no established pharmaceuticals in the EAC states.
520 $a It is against this background that this research makes an argument against the aforementioned policy. It will be demonstrated that the policy is biased towards ensuring access to medicines through price-reduction, at the expense of patent protection. This approach is inappropriate because: first, given the absence of market incentives to invest in developing medicines for African diseases, the policy will only worsen the already bad situation since it undermines the strongest alternative incentive (patent protection); and second, such a policy will not only discourage foreign pharmaceuticals further but also suppress domestic pharmaceutical activity, which is undoubtedly necessary in view of the growing neglect of African diseases by foreign pharmaceuticals.
590 $a School code: 6004.
650 4 $a Intellectual property. $3 572975
650 4 $a International law. $3 560784
690 $a 0513
690 $a 0616
710 2 $a University of Pretoria (South Africa). $b Law. $3 3188930
773 0 $t Masters Abstracts International $g 54-06(E).
790 $a 6004
791 $a LLM
792 $a 2014
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1594680